H05Phase 1/2 study of nivolumab with or without ipilimumab...

Annals of Oncology 2015 / 10 Vol. 26; Iss. suppl 6

H05Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

Antonia, S.J., Bendell, J., Taylor, M., Calvo, E., Jäger, D., de Braud, F., Ott, P.A., Pietanza, M.C., Horn, L., Le, D.T., Morse, M.A., López-Martin, J.A., Ascierto, P.A., Christensen, O., Grosso, J.F
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv343.05
Date:
October, 2015
File:
PDF, 36 KB
english, 2015
Conversion to is in progress
Conversion to is failed